Ben Barres, a neuroscientist whose work on the previously little-researched topic of the brain’s glial cells laid the foundation for much of the ongoing work for medications to treat Alzheimer’s disease, has passed away of pancreatic cancer.
He was the first transgender person to be admitted to the National Academies of Science, was an inspirational teacher, and was an outspoken advocate for the dignity and rights of all persons.
